Call Options

27 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $71,910 - $85,800
3,000 Added 4.63%
67,800 $1.86 Million
Q2 2024

Aug 15, 2024

BUY
$17.98 - $25.47 $546,592 - $774,288
30,400 Added 88.37%
64,800 $1.59 Million
Q1 2024

May 07, 2024

BUY
$17.59 - $23.59 $605,096 - $811,496
34,400 New
34,400 $733,000
Q3 2023

Nov 14, 2023

BUY
$15.99 - $23.22 $147,108 - $213,624
9,200 Added 52.87%
26,600 $426,000
Q2 2023

Aug 11, 2023

BUY
$17.56 - $23.76 $56,191 - $76,032
3,200 Added 22.54%
17,400 $403,000
Q1 2023

May 16, 2023

BUY
$15.26 - $23.75 $216,692 - $337,250
14,200 New
14,200 $329,000
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $336,885 - $515,780
18,500 Added 140.15%
31,700 $605,000
Q2 2022

Aug 15, 2022

SELL
$16.45 - $25.88 $34,545 - $54,348
-2,100 Reduced 13.73%
13,200 $240,000
Q1 2022

May 16, 2022

SELL
$22.67 - $28.01 $963,475 - $1.19 Million
-42,500 Reduced 73.53%
15,300 $386,000
Q4 2021

Feb 14, 2022

SELL
$24.13 - $32.63 $439,166 - $593,866
-18,200 Reduced 23.95%
57,800 $1.6 Million
Q3 2021

Nov 15, 2021

BUY
$29.97 - $36.66 $422,577 - $516,905
14,100 Added 22.78%
76,000 $2.45 Million
Q2 2021

Aug 11, 2021

BUY
$25.39 - $32.61 $66,014 - $84,786
2,600 Added 4.38%
61,900 $1.89 Million
Q1 2021

May 17, 2021

BUY
$19.92 - $31.6 $330,672 - $524,560
16,600 Added 38.88%
59,300 $1.81 Million
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $164,160 - $266,895
13,500 Added 46.23%
42,700 $844,000
Q3 2020

Nov 16, 2020

SELL
$11.25 - $14.75 $285,750 - $374,650
-25,400 Reduced 46.52%
29,200 $381,000
Q2 2020

Aug 14, 2020

BUY
$10.69 - $16.49 $307,872 - $474,911
28,800 Added 111.63%
54,600 $619,000
Q1 2020

May 15, 2020

SELL
$9.78 - $29.53 $298,290 - $900,665
-30,500 Reduced 54.17%
25,800 $369,000
Q4 2019

Feb 14, 2020

SELL
$20.93 - $35.1 $824,642 - $1.38 Million
-39,400 Reduced 41.17%
56,300 $1.53 Million
Q3 2019

Nov 14, 2019

BUY
$22.08 - $47.08 $699,936 - $1.49 Million
31,700 Added 49.53%
95,700 $2.74 Million
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $920,402 - $1.42 Million
40,600 Added 173.5%
64,000 $1.78 Million
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $304,309 - $392,110
11,300 Added 93.39%
23,400 $777,000
Q4 2018

Feb 14, 2019

SELL
$27.23 - $45.56 $1.92 Million - $3.21 Million
-70,500 Reduced 85.35%
12,100 $352,000
Q3 2018

Nov 14, 2018

BUY
$37.57 - $50.34 $1.38 Million - $1.85 Million
36,800 Added 80.35%
82,600 $3.8 Million
Q2 2018

Aug 14, 2018

SELL
$27.75 - $40.17 $1.5 Million - $2.18 Million
-54,200 Reduced 54.2%
45,800 $1.71 Million
Q1 2018

May 15, 2018

BUY
$28.83 - $41.01 $945,624 - $1.35 Million
32,800 Added 48.81%
100,000 $2.96 Million
Q4 2017

Feb 14, 2018

SELL
$28.45 - $37.14 $341,400 - $445,680
-12,000 Reduced 15.15%
67,200 $2.31 Million
Q3 2017

Nov 14, 2017

BUY
$24.01 - $36.2 $1.9 Million - $2.87 Million
79,200
79,200 $2.87 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.